Security key
34962G208
Forte Biosciences, Inc. - Common Stock (FBRX)
CUSIP: 34962G208
Q3 2025 13F Holders as of 30 Sep 2025
- Security type / class
- Equity / Common Stock
- Shares outstanding
- 6,120,451
- Total 13F shares
- 10,343,866
- Share change
- +391,054
- Total reported value
- $155,080,846
- Reported price per share
- $15.00
- Number of holders
- 42
- Value change
- +$6,727,909
- Number of buys
- 27
- Number of sells
- 10
Security identity
Holder snapshot
Report period
Q3 2025
Institutions
42
Top holders
10
FBRX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
Previous quarter: Q2 2025
Forte Biosciences, Inc. SEC filings
Forte Biosciences, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 34962G208
Recent filing periods:
Ownership snapshot
Top shareholders of FBRX - Forte Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
FEDERATED HERMES, INC.
13D/G signal
FEDERATED HERMES, INC.
Evidence rows
46
Latest as of
30 Sep 2025
13D/G
13F
3/4/5
Lead comparable stake: 13%
13D/G row: FEDERATED HERMES, INC.
Showing 1-8 of 46 holder rows.
Rank 1 holder
FEDERATED HERMES, INC.
13D/G
13F
- Ownership
- 13%
- Position
- $18.69M
Rank 2 holder
TYBOURNE CAPITAL MANAGEMENT (HK) LTD
13D/G
13F
- Ownership
- 10%
- Position
- $13.38M
Rank 3 holder
ORBIMED ADVISORS LLC
13F
13D/G
- Ownership
- 8%
- Position
- $15.48M
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FEDERATED HERMES, INC. |
13D/G
13F
Company
|
13%
|
$18,692,393
1,635,380 shares
|
+$1,791,458 | 30 Sep 2025 |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD |
13D/G
13F
Company
|
10%
|
$13,378,307
1,268,086 shares
|
+$6,618,184 | 30 Jun 2025 |
| ORBIMED ADVISORS LLC |
13F
13D/G
Company
|
8%
from 13D/G
|
$15,476,628
1,196,955 shares
|
— | 30 Jun 2025 |
| Ikarian Capital, LLC |
13D/G
13F
Company
|
5%
|
$6,516,387
617,667 shares
|
+$89,063 | 30 Jun 2025 |
| Farallon Capital Partners, L.P. |
13D/G
Dapice Joshua J.
|
3.4%
|
$12,130
221,027 shares
|
$0 | 31 Dec 2024 |
| PERCEPTIVE ADVISORS LLC |
13D/G
13F
Company
|
2.5%
|
$1,209,840
163,935 shares
|
$0 | 31 Dec 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
13D/G
Company
|
0.8%
from 13D/G
|
$758,176
58,637 shares
|
— | 30 Jun 2025 |
| BIOTECHNOLOGY VALUE FUND L P |
13D/G
BVF PARTNERS L P/IL
|
0.5%
|
$980,250
65,350 shares
|
-$8,674,080 | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
42
Shares
10,343,866
Rows loaded
42
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
33
Q3 2025 holders
42
Holder diff
9
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 value | Q3 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend